ALK and non-small cell lung carcinoma: Most of the studies proposed the AI-based models for the identification of Epidermal growth factor receptor (EGFR) biomarker in non-small cell lung cancer (NSCLC), followed by Programmed death-ligand 1 (PD-L1) and anaplastic lymphoma kinase (ALK).